NR1H4 and metabolic dysfunction-associated steatotic liver disease: Dysregulation of FXR signaling has been linked to metabolic diseases such as obesity, type 2 diabetes, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis [64,65].